How point-of-care testing could drive innovation in global health.

In areas of limited resources, point-of-care diagnostic testing is being increasingly used to identify disease, determine prognosis, and monitor treatment. Investments in new diagnostics are starting to improve care. Health systems need to evolve to reap benefits for global health.

[1]  Anna Vassall,et al.  Rapid Diagnosis of Tuberculosis with the Xpert MTB/RIF Assay in High Burden Countries: A Cost-Effectiveness Analysis , 2011, PLoS medicine.

[2]  K. D. de Cock,et al.  Unfinished business--expanding HIV testing in developing countries. , 2006, The New England journal of medicine.

[3]  Marco Schito,et al.  Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis. , 2012, The Journal of infectious diseases.

[4]  R. Elghanian,et al.  p24 Antigen Rapid Test for Diagnosis of Acute Pediatric HIV Infection , 2010, Journal of acquired immune deficiency syndromes.

[5]  Robert W Snow,et al.  The effect of mobile phone text-message reminders on Kenyan health workers' adherence to malaria treatment guidelines: a cluster randomised trial , 2011, The Lancet.

[6]  B. Nagy,et al.  Evaluation of a rapid and simple placental growth factor test in hypertensive disorders of pregnancy , 2013, Hypertension Research.

[7]  R. Peeling,et al.  Performance of a dipstick dye immunoassay for rapid screening of Schistosoma japonicum infection in areas of low endemicity , 2011, Parasites & Vectors.

[8]  Bernhard Weigl,et al.  Instrument-free nucleic acid amplification assays for global health settings , 2011, Defense + Commercial Sensing.

[9]  Rosanna W. Peeling,et al.  Point-of-Care Tests to Strengthen Health Systems and Save Newborn Lives: The Case of Syphilis , 2012, PLoS medicine.

[10]  D. Hamer,et al.  Community Case Management of Fever Due to Malaria and Pneumonia in Children Under Five in Zambia: A Cluster Randomized Controlled Trial , 2010, PLoS medicine.

[11]  K. Chua,et al.  A point-of-care test for measles diagnosis: detection of measles-specific IgM antibodies and viral nucleic acid. , 2011, Bulletin of the World Health Organization.

[12]  L. Myer,et al.  Impact of on-site testing for maternal syphilis on treatment delays, treatment rates, and perinatal mortality in rural South Africa: a randomised controlled trial , 2003, Sexually transmitted infections.

[13]  D. Birx,et al.  Laboratory Systems and Services Are Critical in Global Health , 2010, American journal of clinical pathology.

[14]  Elizabeth A. Hesse,et al.  Adolescent women can perform a point-of-care test for trichomoniasis as accurately as clinicians , 2010, Sexually Transmitted Infections.

[15]  S. Reid,et al.  Strengthening Health Systems at Facility-Level: Feasibility of Integrating Antiretroviral Therapy into Primary Health Care Services in Lusaka, Zambia , 2010, PloS one.

[16]  N. Rollins,et al.  Rapid Testing May Not Improve Uptake of HIV Testing and Same Day Results in a Rural South African Community: A Cohort Study of 12,000 Women , 2008, PloS one.

[17]  S. Dalal,et al.  Provider-Initiated HIV Testing and Counseling: Increased Uptake in Two Public Community Health Centers in South Africa and Implications for Scale-Up , 2011, PLoS ONE.

[18]  S. S. Olmsted,et al.  Requirements for high impact diagnostics in the developing world , 2006, Nature.

[19]  John Stover,et al.  Towards an improved investment approach for an effective response to HIV/AIDS , 2011, The Lancet.

[20]  Yuesheng Li,et al.  Diagnosis and management of schistosomiasis , 2011, BMJ : British Medical Journal.

[21]  M. Fox,et al.  Rapid Point-of-Care CD4 Testing at Mobile HIV Testing Sites to Increase Linkage to Care: An Evaluation of a Pilot Program in South Africa , 2012, Journal of acquired immune deficiency syndromes.

[22]  M. Chopra,et al.  The failure of routine rapid HIV testing: a case study of improving low sensitivity in the field , 2010, BMC health services research.

[23]  D. Sridhar,et al.  Global health funding: how much, where it comes from and where it goes. , 2009, Health policy and planning.

[24]  C. Whitty,et al.  Rapid testing for malaria in settings where microscopy is available and peripheral clinics where only presumptive treatment is available: a randomised controlled trial in Ghana , 2010, BMJ : British Medical Journal.

[25]  Till Bärnighausen,et al.  Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. , 2011, The Lancet. Infectious diseases.

[26]  J. Nkengasong.  A shifting paradigm in strengthening laboratory health systems for global health: acting now, acting collectively, but acting differently. , 2010, American journal of clinical pathology.

[27]  Eduardo Gotuzzo,et al.  Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study , 2011, The Lancet.

[28]  S. Lawn,et al.  Tuberculosis in Antiretroviral Treatment Services in Resource-Limited Settings: Addressing the Challenges of Screening and Diagnosis , 2011, The Journal of infectious diseases.

[29]  S. Rosen,et al.  Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review , 2011, PLoS medicine.

[30]  J. Nkengasong,et al.  Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and Opportunities , 2011, Clinical Microbiology Reviews.

[31]  Samuel K Sia,et al.  Lab-on-a-chip devices for global health: past studies and future opportunities. , 2007, Lab on a chip.

[32]  P. Yager,et al.  Point-of-care diagnostics for global health. , 2008, Annual review of biomedical engineering.

[33]  M. Pai,et al.  Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs. , 2012, Discovery medicine.

[34]  W. MacLeod,et al.  The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa , 2012, PloS one.

[35]  Trevor F Peter,et al.  Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study , 2011, The Lancet.

[36]  Angelika Niemz,et al.  Point-of-care nucleic acid testing for infectious diseases. , 2011, Trends in biotechnology.

[37]  R. Snow,et al.  Microscopy and outpatient malaria case management among older children and adults in Kenya , 2006, Tropical medicine & international health : TM & IH.